{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:54:20Z","timestamp":1764996860864},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,12,13]],"date-time":"2008-12-13T00:00:00Z","timestamp":1229126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s10552-008-9267-x","type":"journal-article","created":{"date-parts":[[2008,12,12]],"date-time":"2008-12-12T15:15:33Z","timestamp":1229094933000},"page":"591-599","source":"Crossref","is-referenced-by-count":9,"title":["Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study"],"prefix":"10.1007","volume":"20","author":[{"name":"PANKRAS II Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Crous-Bou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e0s","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Carrato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Puigdom\u00e8nech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco X.","family":"Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,13]]},"reference":[{"key":"9267_CR1","first-page":"233","volume-title":"Textbook of cancer epidemiology","author":"A Ekbom","year":"2002","unstructured":"Ekbom A, Hunter D (2002) Pancreatic cancer. In: Adami HO, Hunter D, Trichopoulos D (eds) Textbook of cancer epidemiology. Oxford University Press, New York, pp 233\u2013247"},{"key":"9267_CR2","first-page":"103","volume-title":"Pancreatic cancer","author":"D Li","year":"2005","unstructured":"Li D, Jiao L, Porta M (2005) Epidemiology. In: von Hoff DD, Evans DB, Hruban RH (eds) Pancreatic cancer. Jones & Bartlett, Boston, pp 103\u2013117"},{"key":"9267_CR3","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/j.1572-0241.2007.01510.x","volume":"102","author":"MM Hassan","year":"2007","unstructured":"Hassan MM, Bondy ML, Wolff RA et al (2007) Risk factors for pancreatic cancer: case\u2013control study. Am J Gastroenterol 102:2696\u20132707","journal-title":"Am J Gastroenterol"},{"key":"9267_CR4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/mpa.0b013e318053e7d3","volume":"35","author":"AC Lo","year":"2007","unstructured":"Lo AC, Soliman AS, El-Ghawalby N et al (2007) Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas 35:120\u2013129. doi: 10.1097\/mpa.0b013e318053e7d3","journal-title":"Pancreas"},{"key":"9267_CR5","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076\u20132083. doi: 10.1038\/sj.bjc.6602619","journal-title":"Br J Cancer"},{"key":"9267_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2169\/internalmedicine.46.1787","volume":"46","author":"M Otsuki","year":"2007","unstructured":"Otsuki M, Tashiro M (2007) Chronic pancreatitis and pancreatic cancer, lifestyle-related diseases. Intern Med 46:109\u2013113. doi: 10.2169\/internalmedicine.46.1787","journal-title":"Intern Med"},{"key":"9267_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ijc.22123","volume":"120","author":"J Luo","year":"2007","unstructured":"Luo J, Nordenvall C, Nyr\u00e9n O, Adami HO, Permert J, Ye W (2007) The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease. Int J Cancer 120:368\u2013372. doi: 10.1002\/ijc.22123","journal-title":"Int J Cancer"},{"key":"9267_CR8","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1158\/1055-9965.EPI-05-0119","volume":"14","author":"S Gandini","year":"2005","unstructured":"Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P (2005) Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev 14:1908\u20131916. doi: 10.1158\/1055-9965.EPI-05-0119","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9267_CR9","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/sj.bjc.6690607","volume":"80","author":"DT Silverman","year":"1999","unstructured":"Silverman DT, Schiffman M, Everhart J et al (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80:1830\u20131837. doi: 10.1038\/sj.bjc.6690607","journal-title":"Br J Cancer"},{"key":"9267_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/gut.48.2.143","volume":"48","author":"E Efthimiou","year":"2001","unstructured":"Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA (2001) Inherited predisposition to pancreatic cancer. Gut 48:143\u2013147","journal-title":"Gut"},{"key":"9267_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bpg.2005.10.001","volume":"20","author":"AB Lowenfels","year":"2006","unstructured":"Lowenfels AB, Maisonneuve P (2006) Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20:197\u2013209. doi: 10.1016\/j.bpg.2005.10.001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"9267_CR12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/j.gastro.2008.07.033","volume":"135","author":"FX Real","year":"2008","unstructured":"Real FX, Cibri\u00e1n-Uhalte E, Martinelli P (2008) Pancreatic cancer development and progression: remodeling the model. Gastroenterology 135:724\u2013728. doi: 10.1053\/j.gastro.2008.07.033","journal-title":"Gastroenterology"},{"key":"9267_CR13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc949","volume":"2","author":"N Bardeesy","year":"2002","unstructured":"Bardeesy N, DePinho RA (2002) Pancreatic cancer biology and genetics. Nat Rev Cancer 2:897\u2013909","journal-title":"Nat Rev Cancer"},{"key":"9267_CR14","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","volume":"20","author":"AF Hezel","year":"2006","unstructured":"Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20:1218\u20131249. doi: 10.1101\/gad.1415606","journal-title":"Genes Dev"},{"key":"9267_CR15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.MP.0000086072.56290.FB","volume":"16","author":"A Maitra","year":"2003","unstructured":"Maitra A, Adsay NV, Argani P et al (2003) Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16:902\u2013912. doi: 10.1097\/01.MP.0000086072.56290.FB","journal-title":"Mod Pathol"},{"key":"9267_CR16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","volume":"3","author":"M Malumbres","year":"2003","unstructured":"Malumbres M, Barbacid M (2003) RAS oncogenes: the first 30\u00a0years. Nat Rev Cancer 3:459\u2013465. doi: 10.1038\/nrc1097","journal-title":"Nat Rev Cancer"},{"key":"9267_CR17","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(99)04232-4","volume":"354","author":"M Porta","year":"1999","unstructured":"Porta M, Malats N, Jariod M et al (1999) Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. Lancet 354:2125\u20132129. doi: 10.1016\/S0140-6736(99)04232-4","journal-title":"Lancet"},{"key":"9267_CR18","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/ijc.21986","volume":"119","author":"AS Soliman","year":"2006","unstructured":"Soliman AS, Bondy M, Webb CR et al (2006) Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients. Int J Cancer 119:1455\u20131461. doi: 10.1002\/ijc.21986","journal-title":"Int J Cancer"},{"key":"9267_CR19","first-page":"1223","volume":"9","author":"RJ Slebos","year":"2000","unstructured":"Slebos RJ, Hoppin JA, Tolbert PE et al (2000) K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiol Biomarkers Prev 9:1223\u20131232","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9267_CR20","first-page":"139","volume":"37","author":"JP Fryzek","year":"2006","unstructured":"Fryzek JP, Garabrant DH, Schenk M, Kinnard M, Greenson JK, Sarkar FH (2006) The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations. Int J Gastrointest Cancer 37:139\u2013145","journal-title":"Int J Gastrointest Cancer"},{"key":"9267_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.mpa.0000246665.68869.d4","volume":"34","author":"L Jiao","year":"2007","unstructured":"Jiao L, Zhu J, Hassan MM, Evans DB, Abbruzzese JL, Li D (2007) K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. Pancreas 34:55\u201362. doi: 10.1097\/01.mpa.0000246665.68869.d4","journal-title":"Pancreas"},{"key":"9267_CR22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.sla.0000128681.76786.07","volume":"239","author":"B Farrow","year":"2004","unstructured":"Farrow B, Sugiyama Y, Chen A, Uffort E, Nealon W, Evers BM (2004) Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg 239:763\u2013771. doi: 10.1097\/01.sla.0000128681.76786.07","journal-title":"Ann Surg"},{"key":"9267_CR23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm0105-20","volume":"11","author":"M Karin","year":"2005","unstructured":"Karin M (2005) Inflammation and cancer: the long reach of Ras. Nat Med 11:20\u201321. doi: 10.1038\/nm0105-20","journal-title":"Nat Med"},{"key":"9267_CR24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4161\/cc.4.6.1714","volume":"4","author":"A Sparmann","year":"2005","unstructured":"Sparmann A, Bar-Sagi D (2005) Ras oncogene and inflammation: partners in crime. Cell Cycle 4:735\u2013736","journal-title":"Cell Cycle"},{"key":"9267_CR25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1358\/mf.2006.28.3.985230","volume":"28","author":"R Schiel","year":"2006","unstructured":"Schiel R, Beltschikow W, Steiner T, Stein G (2006) Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol 28:169\u2013175. doi: 10.1358\/mf.2006.28.3.985230","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"9267_CR26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF02592575","volume":"25","author":"D Basso","year":"1995","unstructured":"Basso D, Plebani M, Fogar P et al (1995) Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes. Int J Clin Lab Res 25:40\u201343. doi: 10.1007\/BF02592575","journal-title":"Int J Clin Lab Res"},{"key":"9267_CR27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1007692408457","volume":"16","author":"M Porta","year":"2000","unstructured":"Porta M, Costafreda S, Malats N et al (2000) Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. Eur J Epidemiol 16:533\u2013541. doi: 10.1023\/A:1007692408457","journal-title":"Eur J Epidemiol"},{"key":"9267_CR28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jech.53.11.702","volume":"53","author":"M Porta","year":"1999","unstructured":"Porta M, Malats N, Guarner L et al (1999) Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health 53:702\u2013709","journal-title":"J Epidemiol Community Health"},{"key":"9267_CR29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gut.48.1.70","volume":"48","author":"N Malats","year":"2001","unstructured":"Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX (2001) The cystic fibrosis transmembrane regulator (CFTR) \u0394F508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreas cancer. Gut 48:70\u201374","journal-title":"Gut"},{"key":"9267_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/carcin\/23.1.101","volume":"23","author":"J Alguacil","year":"2002","unstructured":"Alguacil J, Porta M, Malats N et al (2002) Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer. Carcinogenesis 23:101\u2013106","journal-title":"Carcinogenesis"},{"key":"9267_CR31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/gut.50.5.653","volume":"50","author":"FX Real","year":"2002","unstructured":"Real FX, Malats N, Lesca G et al (2002) Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreas cancer. Gut 50:653\u2013657","journal-title":"Gut"},{"key":"9267_CR32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02712816","volume":"7","author":"M Porta","year":"2005","unstructured":"Porta M, Fabregat X, Malats N et al (2005) Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol 7:189\u2013197","journal-title":"Clin Transl Oncol"},{"key":"9267_CR33","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1023\/A:1026635005363","volume":"44","author":"M Soler","year":"1999","unstructured":"Soler M, Malats N, Porta M et al (1999) Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. Dig Dis Sci 44:2469\u20132477","journal-title":"Dig Dis Sci"},{"key":"9267_CR34","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0895-4356(98)00130-9","volume":"51","author":"M Soler","year":"1998","unstructured":"Soler M, Porta M, Malats N et al (1998) Learning from case-reports: diagnostic issues in an epidemiologic study of pancreatic cancer. J Clin Epidemiol 51:1215\u20131221","journal-title":"J Clin Epidemiol"},{"key":"9267_CR35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0213-9111(95)71258-4","volume":"9","author":"L Gavald\u00e0","year":"1995","unstructured":"Gavald\u00e0 L, Porta M, Malats N et al (1995) Agreement between information supplied by the patient and a family member on medical history, consumption of tobacco, alcohol and coffee and diet in cancer of the exocrine pancreas and extrahepatic biliary tract. Gac Sanit 9:334\u2013342","journal-title":"Gac Sanit"},{"key":"9267_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/mpa.0b013e31805d8fa4","volume":"35","author":"M Crous-Bou","year":"2007","unstructured":"Crous-Bou M, Porta M, L\u00f3pez T et al (2007) Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas 35:135\u2013141. doi: 10.1097\/mpa.0b013e31805d8fa4","journal-title":"Pancreas"},{"key":"9267_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0006-341X.2004.00154.x","volume":"60","author":"PR Rosenbaum","year":"2004","unstructured":"Rosenbaum PR (2004) The case-only odds ratio as a causal parameter. Biometrics 60:233\u2013240. doi: 10.1111\/j.0006-341X.2004.00154.x","journal-title":"Biometrics"},{"key":"9267_CR38","doi-asserted-by":"crossref","DOI":"10.1002\/9780470773666","volume-title":"Statistical methods in medical research","author":"P Armitage","year":"2002","unstructured":"Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research, 4th edn. Blackwell, Oxford","edition":"4"},{"key":"9267_CR39","volume-title":"Modern epidemiology","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL (eds) (2008) Modern epidemiology, 3rd edn. Lippincott-Raven, Philadelphia","edition":"3"},{"key":"9267_CR40","first-page":"241","volume-title":"An introduction to medical statistics","author":"M Bland","year":"1987","unstructured":"Bland M (1987) An introduction to medical statistics. Oxford Medical Publications, Oxford, pp 241\u2013265"},{"key":"9267_CR41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3748\/wjg.v10.i6.881","volume":"10","author":"YX Ren","year":"2004","unstructured":"Ren YX, Xu GM, Li ZS, Song YG (2004) Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases. World J Gastroenterol 10:881\u2013884","journal-title":"World J Gastroenterol"},{"key":"9267_CR42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2168.1998.00630.x","volume":"85","author":"S Gansauge","year":"1998","unstructured":"Gansauge S, Schmid RM, Muller J, Adler G, Mattfeldt T, Beger HG (1998) Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Br J Surg 85:337\u2013340","journal-title":"Br J Surg"},{"key":"9267_CR43","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/1097-0142(20000601)88:11<2495::AID-CNCR10>3.0.CO;2-B","volume":"88","author":"J Luttges","year":"2000","unstructured":"Luttges J, Diederichs A, Menke MA, Vogel I, Kremer B, Kloppel G (2000) Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53. Cancer 88:2495\u20132504","journal-title":"Cancer"},{"key":"9267_CR44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1593\/neo.04445","volume":"7","author":"M L\u00f6hr","year":"2005","unstructured":"L\u00f6hr M, Kloppel G, Maisonneuve P, Lowenfels AB, Luttges J (2005) Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 7:17\u201323. doi: 10.1593\/neo.04445","journal-title":"Neoplasia"},{"key":"9267_CR45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccr.2007.01.012","volume":"11","author":"C Guerra","year":"2007","unstructured":"Guerra C, Schuhmacher AJ, Canamero M et al (2007) Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-ras oncogenes in adult mice. Cancer Cell 11:291\u2013302. doi: 10.1016\/j.ccr.2007.01.012","journal-title":"Cancer Cell"},{"key":"9267_CR46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","volume":"4","author":"H Lu","year":"2006","unstructured":"Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221\u2013233. doi: 10.1158\/1541-7786.MCR-05-0261","journal-title":"Mol Cancer Res"},{"key":"9267_CR47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867. doi: 10.1038\/nature01322","journal-title":"Nature"},{"key":"9267_CR48","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1101\/gad.1583307","volume":"21","author":"D Hanahan","year":"2007","unstructured":"Hanahan D, Wagner EF, Palmiter RD (2007) The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer. Genes Dev 21:2258\u20132270. doi: 10.1101\/gad.1583307","journal-title":"Genes Dev"},{"key":"9267_CR49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/jech.56.10.734","volume":"56","author":"M Porta","year":"2002","unstructured":"Porta M, Malats N, Vioque J et al (2002) Incomplete overlapping of biological, clinical and environmental information in molecular epidemiologic studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health 56:734\u2013738. doi: 10.1136\/jech.56.10.734","journal-title":"J Epidemiol Community Health"},{"key":"9267_CR50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0895-4356(94)90123-6","volume":"47","author":"M Porta","year":"1994","unstructured":"Porta M, Malats N, Pi\u00f1ol JL, Rif\u00e0 J, Andreu M, Real FX (1994) Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. J Clin Epidemiol 47:1069\u20131079. doi: 10.1016\/0895-4356(94)90123-6","journal-title":"J Clin Epidemiol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-008-9267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-008-9267-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-008-9267-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:05:59Z","timestamp":1559235959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-008-9267-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,13]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9267"],"URL":"https:\/\/doi.org\/10.1007\/s10552-008-9267-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2008,12,13]]}}}